In a must-attend series of webinars offered at no cost, entrepreneurs and owners of emerging life sciences companies will learn how to craft the cost-efficient legal strategies required to start, develop and maximize the value of their businesses.
CHI presents The Blueprint™ in collaboration with Duane Morris, a global law firm focused on the emerging life sciences space. The Blueprint™ provides a step-by-step guide to establishing and financing your business; obtaining, protecting and partnering your intellectual property; dealing with FDA regulations; maintaining effective employment practices; recognizing and minimizing risk; and ensuring continued success once on the market.
This weeks topic: Financing, M&A and Exit Strategies presented by Richard Silfen of Duane Morris.
About the Presenter
Richard A. Silfen heads the Capital Markets Group of the firm’s Corporate Practice Group and practices in the area of corporate law with concentrations in securities and mergers and acquisitions. Mr. Silfen advises publicly traded companies in connection with public and private debt and equity securities offerings. He also advises companies with regard to mergers and acquisition transactions. Mr. Silfen also advises clients in connection with private equity investments in publicly traded and privately owned issuers, senior, high-yield, mezzanine and other debt issuances using complex structures and restructurings of multi-layer debt.
In addition, Mr. Silfen assists emerging and other businesses to develop plans for the growth and development of their businesses and technologies, including financing transactions, collaborative and strategic partnerships, and joint venture arrangements. Mr. Silfen also works with clients to facilitate public reporting and analysis of operating results, advises on internal audit functions and other Sarbanes-Oxley compliance, and works with clients to support and enhance strategies for communication with security analysts and investors.
Chambers USA: America’s Leading Lawyers for Business has included Mr. Silfen in its editions since 2009 as one of the leading corporate lawyers in Pennsylvania for his advice on M&A, private equity and securities matters. Mr. Silfen has been included in two corporate categories for Chambers listings: Corporate/M&A & Private Equity and Corporate/M&A: Securities. Chambers says that Mr. Silfen is described as “a very smart lawyer.” He advises on M&A, private equity and securities matters.
Mr. Silfen is a 1987 graduate of the University of Alabama School of Law and a graduate of Baylor University.
About the Blueprint
The Blueprint™ will unfold as a series of 12 webinars, to be held on alternate Tuesdays from 9:00 a.m. to 10:00 a.m. (Pacific time). Take advantage of this unique opportunity to leverage your concept, whether in biotech, pharma, medical devices, diagnostics, wireless health, informatics or other areas.